Serum Nutrient Levels and Aging Effects on Periodontitis by Ebersole, Jeffrey L et al.
University of Kentucky
UKnowledge
Biostatistics Faculty Publications Biostatistics
12-15-2018
Serum Nutrient Levels and Aging Effects on
Periodontitis
Jeffrey L Ebersole
University of Nevada - Las Vegas
Joshua Lambert
University of Cincinnati
Heather Bush
University of Kentucky, heather.bush@uky.edu
Pinar Emecen Huja
Medical University of South Carolina
Arpita Basu
University of Nevada - Las Vegas
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/biostatistics_facpub
Part of the Biostatistics Commons, Dentistry Commons, and the Diseases Commons
This Article is brought to you for free and open access by the Biostatistics at UKnowledge. It has been accepted for inclusion in Biostatistics Faculty
Publications by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.
Repository Citation
Ebersole, Jeffrey L; Lambert, Joshua; Bush, Heather; Huja, Pinar Emecen; and Basu, Arpita, "Serum Nutrient Levels and Aging Effects
on Periodontitis" (2018). Biostatistics Faculty Publications. 36.
https://uknowledge.uky.edu/biostatistics_facpub/36
Serum Nutrient Levels and Aging Effects on Periodontitis
Notes/Citation Information
Published in Nutrients, v. 10, issue 12, 1986, p. 1-19.
© 2018 by the authors. Licensee MDPI, Basel, Switzerland.
This article is an open access article distributed under the terms and conditions of the Creative Commons
Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Digital Object Identifier (DOI)
https://doi.org/10.3390/nu10121986
This article is available at UKnowledge: https://uknowledge.uky.edu/biostatistics_facpub/36
nutrients
Article
Serum Nutrient Levels and Aging Effects
on Periodontitis
Jeffrey L. Ebersole 1,* , Joshua Lambert 2, Heather Bush 3, Pinar Emecen Huja 4 and Arpita Basu 5
1 Department of Biomedical Sciences, School of Dental Medicine, University of Nevada Las Vegas,
1001 Shadow Lane, B221, MS 7425, Las Vegas, NV 89106, USA
2 College of Nursing, University of Cincinnati; Cincinnati, OH 45221, USA; lambejw@ucmail.uc.edu
3 Department of Biostatistics, College of Public Health, University of Kentucky; Lexington, KY 40536, USA;
heather.bush@uky.edu
4 Department of Periodontics, School of Dentistry, Medical University of South Carolina;
Charleston, SC 29425, USA; emecenh@musc.edu
5 Department of Kinesiology and Nutrition Sciences, School of Allied Health Sciences,
University of Nevada Las Vegas, Las Vegas, NV 89106, USA; arpita.basu@unlv.edu
* Correspondence: jeffrey.ebersole@unlv.edu
Received: 30 October 2018; Accepted: 12 December 2018; Published: 15 December 2018


Abstract: Periodontal disease damages tissues as a result of dysregulated host responses against the
chronic bacterial biofilm insult and approximately 50% of US adults >30 years old exhibit periodontitis.
The association of five blood nutrients and periodontitis were evaluated due to our previous findings
regarding a potential protective effect for these nutrients in periodontal disease derived from the US
population sampled as part of the National Health and Nutrition Examination Survey (1999–2004).
Data from over 15,000 subjects was analyzed for blood levels of cis-β-carotene, β-cryptoxanthin,
folate, vitamin D, and vitamin E, linked with analysis of the presence and severity of periodontitis.
Moderate/severe disease patients had lower cis-β-carotene levels across all racial/ethnic groups and
these decreased levels in moderate/severe periodontitis were exacerbated with age. β-cryptoxanthin
demonstrated lower levels in severe disease patients across the entire age range in all racial/ethnic
groups. Folate differences were evident across the various age groups with consistently lower levels
in periodontitis patients >30 years and most pronounced in females. Lower levels of vitamin D were
consistently noted across the entire age range of patients with a greater difference seen in females
with periodontitis. Finally, an analytical approach to identify interactions among these nutrients
related to age and periodontitis showed interactions of vitamin D in females, and folate with race in
the population. These findings suggest that improving specific nutrient intake leading to elevated
blood levels of a combination of these protective factors may provide a novel strategy to affect the
significant increase in periodontitis that occurs with aging.
Keywords: nutrients; periodontitis; aging
1. Introduction
Periodontitis and dental caries remain the two major oral health maladies across the lifespan in
the United States [1]. The National Health and Nutrition Examination Survey (NHANES) (2009–2012)
reported that approximately 50% of US adults greater than 30 years old exhibit periodontitis,
with minorities and older individuals being disproportionately affected [2]. Based on the Global Burden
of Disease 2010 study, severe periodontitis is a significant health burden, affecting approximately 743
million people [3]. Periodontal disease damages tissues as a result of dysregulated host responses
against the chronic bacterial biofilm insult [4–6]. It represents the primary basis of adult tooth
loss, substantially affecting the individual’s quality of life [7–9]. Similar to many chronic diseases,
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periodontal disease is a complex disease driven by genetic and epigenetic influences, patient behaviors,
medication use, and/or environmental factors that promote periodontal disease initiation and
progression [10]. Moreover, smoking is clearly one of the most significant modifiable risk factors
in the pathogenesis of periodontitis and disease extent and severity [11,12].
Considerable effort has occurred in attempting to define various genetic influences on the
population-based extent and severity of the disease [13–16]. These studies have identified some
unique subpopulations with clearly altered host functions that increase susceptibility, based on various
single nucleotide polymorphisms (SNP) or mutations including genes controlling the production
of inflammatory mediators and tissue and bone regulatory molecules [17–22], as well as some
genome-wide association studies (GWAS) that have attempted to identify gene(s) that confer risk for
disease [14,19,23–25]. More recent reports have also described epigenetic alterations in the genomes of
periodontitis patients [26–32]. However, with complex diseases, such as periodontitis, there are likely
a plethora of critical gene–environment interactions that occur to alter individual risk and enable gene
effects to help explain disease phenotypes.
Environmental epidemiology focuses on the discovery of environmental exposures that contribute
to or protect against diseases and the identification of public health actions to effectively manage
the risks associated with harmful exposures. Environmental exposures can be involuntary or
represent occupational exposures and voluntary exposures such as smoking, medications, and diet.
While periodontitis is a localized inflammatory process mediating destruction of soft and hard
periodontal tissues [33] resulting from the chronic disruption of the oral epithelial barrier, this disease
triggers systemic inflammatory host responses that may contribute to other systemic conditions
(e.g., cardiovascular disease, diabetes, Alzheimer’s disease [34–37]). Additionally, the systemic
contribution to the microenvironment in periodontal tissues is a critical component for maintaining
homeostasis or influencing the progression of disease [38]. This breadth of data identifies the need
for optimal oral health as an integral component of the prevention and management of chronic
health conditions.
Observational studies have shown a strong correlation between the intake of fruits and vegetables
and other antioxidant nutrients, with oral health-related quality of life in adults [39–42]. These effects
have been mainly attributed to their function in reducing oxidative stress and inflammation, and were
related to intake of β-carotene, vitamin C, a-tocopherol, and omega-3-fatty acids [33,43,44]. However,
while dietary nutrients and specific bioactive compounds have emerged as influential factors in the
etiology and progression of periodontitis [45], a recent systematic review [46] emphasized associations,
but also the general lack of clear data supporting causal relationships.
We have reported on an Environment-Wide Association Study of periodontitis in data derived
from the National Health and Nutrition Examination Survey from 1999–2004 [47]. These findings
identified a number of environmental toxins/factors that significantly increased the prevalence of
periodontitis, particularly related to age, race/ethnicity, and smoking status. However, we also
noted a number of serum nutrients that were significantly negatively associated with the prevalence,
including cis-β-carotene, vitamin D, vitamin E, folate, and β-cryptoxanthin. These findings are
consistent with recent NHANES reports on cis-β-carotene and peripheral artery disease [48] and for
cis-β-carotene, vitamin D, vitamin E, and β-cryptoxanthin coupled with physical activity in lowering
the risk for metabolic syndrome [49]. Linden et al. [50] also reported elevated levels of cis-β-carotene
and β-cryptoxanthin in males from 60–70 years of age associated with decreased periodontitis.
While these reports are promising, further research deserves urgent attention given the high
prevalence of periodontitis in the US and global population. Based on the results from various
experimental models and clinical studies, designing dietary or supplemental formulations may
present as an emerging line of natural therapy for periodontitis and to maximize population levels of
oral health.
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2. Materials and Methods
2.1. Population Data
In this study, periodontal examination data from public-use data files for three NHANES
cohorts—1999–2000, 2001–2002, 2003–2004—were extracted and combined to comprise the study
population. These surveys, using the same methods, assessed the health status of a nationally
representative sample of the civilian non-institutionalized US population, selected through a stratified
multistage probability sampling design. Full descriptions of the sample design for these NHANES
datasets are publically available [51]. NHANES 1999–2000 (N = 9956), 2001–2002 (N = 10,477),
and 2003–2004 (N = 9643) enlisted persons 1 month of age or older. Among the 11,837 participants who
were equal to and older than 18 years of age and had 16 or more teeth, 3745 were collected in the first
cohort (1999–2000), 4258 in the second cohort (2001–2002), and 3834 in the third cohort (2003–2004).
Those with missing smoking status and periodontal parameters were excluded leaving a final analytical
sample of 8884 participants (1999–2000: 2738; 2001–2002: 3294; 2003–2004: 2852). The NHANES is
a complex, multistage probability sample of non-institutionalized US civilians and subsequently
organized into six unique datasets derived from 2-year cycle population sampling (Centers for Disease
Control and Prevention; National Center for Health Statistics). Each 2-year survey cycle examines a
representative US sample of approximately 10,000 persons and collects health-related data.
2.2. Demographics
The demographic variables considered in this study included age, gender, race, socio-economic
status, smoking status, and number of teeth. Racial-ethnic groups were summarized into five categories:
Mexican American, other Hispanic, non-Hispanic white, non-Hispanic black, and other race, as shown
in Table S1. Socio-economic status, estimated using the poverty income ratio, was computed as the ratio
of family/individual income to the appropriate federal poverty threshold. Smoking status—current
smoker, former smoker, non-smoker—was derived from the two self-reported questions. Participants
reported having historically smoked more than 100 cigarettes, but currently not smoking were defined
as former smokers. Non-smokers were defined as reporting never smoking.
2.3. Clinical Parameters
The analysis included only the records of adults 18 years or older who had a periodontal
examination during the NHANES 1999–2000 (N = 5206), 2001–2002 (N = 5587), and 2003–2004
(N = 5051). Thus, the combined sample for clinical data was 15,844.
Dentists trained in the survey examination protocol conducted the periodontal examinations
collecting probing depth and attachment loss measurements [52–54]. Periodontitis was defined as a site
with clinical attachment loss (CAL) ≥3 mm and a periodontal pocket ≥4 mm. NHANES (1999–2004)
used the partial-mouth periodontal examination (PMPE) protocol to sample teeth and sites. The PMPE
protocols randomly selected two quadrants of the mouth and specified two to three sites per tooth
for measurement of pocket depth, attachment loss, and bleed on probing. In 1999–2000, two sites per
tooth (mid-facial and mesio-facial) were measured, while three sites per tooth (mid-facial, mesio-facial,
and distal) were measured in 2001–2002 and 2003–2004. A periodontal site was defined as a pocket
site with ≥3 mm CAL and ≥4 mm PD (Health and Human Services Vital and Health Statistics Series
11 Report). The gold standard of diagnosing periodontitis using full-mouth examination protocol
yields an approximated prevalence of 22.4% [55,56]. The half-mouth (16 teeth) examination protocol
utilized by NHANES is known to underestimate the national prevalence rate since periodontitis is
site-specific and not evenly distributed in the mouth [55]. Thus, case definition of Series 11 was
chosen because it yielded an estimate (16.9%) in NHANES 2001–2004 that was closest to the gold
standard. The level of periodontitis—mild, moderate, and severe—was defined as described by Page
and Eke [56].
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2.4. Environmental Variables
The environmental factors were categorized into 15 classes based on NHANES categorization.
Environmental variables measured in at least one of the three data cohorts (i.e., 1999–2004) were
included in the study. A total of 156 environmental factors were measured in the NHANES data using
blood and urine samples. These included chemical toxicants, pollutants, allergens, bacterial/viral
organisms, and nutrients. Within the nutrient category there were 16 measures, as shown in Table S2.
Factors with laboratory measurements that had greater than 10% of the observations below a detection
limit threshold defined by NHANES were omitted from analysis. The laboratory measurements using
mass spectrometry and absorption spectroscopy demonstrated that the majority of the variables were
detected in small ranges and were skewed. Thus, all environmental variables were log-transformed
(natural) and standardized and referred to as “processed”. Levels presented were back-transformed
from log-scale values.
2.5. Statistical Approaches
Descriptive statistics were calculated for each serum nutrient, and data are presented as means
and one standard deviation, and stratified by severity of periodontitis, race, and smoking status.
Survey-weighted logistic regressions were performed for each of the processed environmental factors,
adjusting for age, gender, ethnicity, socio-economic status, smoking status, and number of teeth.
The R package “survey” was used in R (Version 3.1.2) for the survey-weighted logistic regression [57].
Weights were constructed in SAS (Version 9.4, Cary, NC, USA) using a 6 year weighting design
from the NHANES variable WTMEC2YR73 [58]. Adjusted odds ratios were calculated with 95%
confidence intervals and were provided to demonstrate the association between the individual factors
and periodontitis. These regressions were repeated by smoking status to examine potential associations
within smoking categories.
Using survey-weighted logistic regressions, subgroup specific effects were explored using the
feasible solution algorithm (FSA) [59]. The FSA can be employed to identify complex subgroup specific
effects in datasets with many variables (such as the NHANES dataset). Subgroup specific effects were
identified using FSA by checking for the statistical significance of two-way interactions. The FSA is
very flexible in the interactions it seeks to identify and can limit the variables it uses in the procedure.
In these analyses, we sought to identify nutrient interactions between age, sex, or race/ethnicity.
Because this process was exploratory in nature, interactions were searched for with the adjustment of
other known covariates or confounders. The odds ratios for the interactions identified are reported as
well as their 95% confidence intervals.
3. Results
Of the nutrients examined in the NHANES dataset, five demonstrated a significant relationship
to the prevalence of periodontitis across the various demographic cohorts; cis-β-carotene, vitamin D,
vitamin E, folate, and β-cryptoxanthin.
Cis-β-carotene is a tetraterpene composed of two retinyl groups, and is broken down in the
mucosa of the human small intestine to retinal, a form of vitamin A. The results in Figure 1A–G
summarize the distribution of cis-β-carotene levels in serum across the population. Figure 1A shows
some decreased level in periodontitis in examining the entire population, which were reflected in
both sexes; however, Figure 1B emphasizes the lower level of this dietary nutrient that becomes more
pronounced at >30 years of age in the patients with periodontitis. Figure 1C explores the levels related
to the severity of periodontitis and shows decreased levels in moderate and severe periodontitis,
which is exacerbated with age, as shown in Figure 1D. Interestingly, even the older mild periodontitis
patients displayed markedly lower level of cis-β-carotene. Based upon previous data supporting
race/ethnicity and smoking as factors in the expression of periodontitis, Figure 1E demonstrates that
severe and/or moderate disease patients had lower cis-β-carotene levels across all the racial/ethnic
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groups. Examination of severity of disease stratified by sex of cis-β-carotene levels is shown in
Figure 1F, demonstrating lowered levels of this nutrient in blood of both sexes with more advanced
disease. Also, while moderate and severe disease smokers had lower levels of this nutrient, in the
non-smokers there was a continuous decrease across all categories of periodontitis versus the subjects
with a healthy periodontium, as shown in Figure 1G.
Figure 1. Levels of cis-β-carotene (µg/dL) in subjects with or without periodontitis stratified upon sex
(A), age (B), disease severity (C), disease severity and age (D), race/ethnicity (E), disease severity and
sex (F), and disease severity in smokers (G). The bars denote group means and the vertical brackets
enclose 1 standared error of the mena (SEM). The asterisk (*) denotes significantly different than the
normal group at p < 0.05.
β-Cryptoxanthin is a member of the class of carotenoids known as xanthophylls and is found in
fruits and vegetables. It is closely related to β-carotene, and can be converted to vitamin A although
not as effectively as the di-retinyl rings of β-carotene. As with other carotenoids, it is an antioxidant
and appears to be associated with decreased risk of some cancers, degenerative diseases, and may
positively affect bone in osteoporosis. Figure 2 provides an overview of the relationship of this dietary
nutrient to periodontitis. Figure 2A shows no difference in levels between normal (non-periodontitis)
Nutrients 2018, 10, 1986 6 of 19
and periodontitis across the entire population or based on sex, nor was there a noticeable effect
of aging on the levels between these 2 groups, as shown in Figure 2B. However, Figure 2C shows
decreased levels in moderate and severe periodontitis patients compared to normal (non-periodontitis)
subjects, and Figure 2D demonstrates lower levels in severe disease patients across the entire age
range. Figure 2E shows lower levels of this nutrient in more advanced diseases in white and black
racial/ethnic groups, although there was no effect and a dramatically higher level of β-cryptoxanthin
in Hispanic subjects. Similar decreased levels were found in moderate-severe disease in both sexes
and in smokers and non-smokers, as shown in Figure 2F,G.
Figure 2. Levels of β-cryptoxanthin in subjects with or without periodontitis stratified upon sex (A),
age (B), disease severity (C), disease severity and age (D), race/ethnicity (E), disease severity and sex
(F), and disease severity in smokers (G). The bars denote group means and the vertical brackets enclose
1 SEM. The asterisk (*) denotes significantly different that other group(s) at p < 0.05.
Folate is one of the B vitamins, vitamin B9, which occurs naturally in many foods, especially
dark green leafy vegetables. Figure 3 summarizes the distribution of folate levels in the NHANES
population, as related to periodontal disease. For the overall population, levels of folate were decreased
in the periodontitis patients and this difference was most pronounced in female subjects, as shown
in Figure 3A. This difference was even more evident across the various age groups with consistently
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lower levels in periodontitis patients >30 years of age, as shown in Figure 3B. Stratified based on
disease severity, small but significant differences were observed in mild and moderate periodontitis
subsets, as shown in Figure 3C. The decreased levels of folate were accentuated in patients >30 years
of age, as shown in Figure 3D. A different pattern of folate levels was noted among the racial/ethnic
groups, with decreasing levels with disease severity in whites and increasing levels in disease severity
in Hispanics. Generally similar levels were seen in the black subjects, as shown in Figure 3E. Related to
disease severity, no consistent differences were seen based upon sex, as shown in Figure 3F. In smokers,
lower folate levels were associated with all levels of periodontitis, although this was not seen in the
non-smoking subgroup, as shown in Figure 3G.
Figure 3. Levels of folate (g/mL) in subjects with or without periodontitis stratified upon sex (A),
age (B), disease severity (C), disease severity and age (D), race/ethnicity (E), disease severity and sex
(F), and disease severity in smokers (G). The bars denote group means and the vertical brackets enclose
1 SEM. The asterisk (*) denotes significantly different than the normal group at p < 0.05.
Vitamin D is technically a group of fat-soluble hormones that impact intestinal absorption of
calcium, magnesium, and phosphate. In particular, vitamin D3 and D2 can be ingested from the
diet, with the major natural source of this vitamin being synthesis from cholesterol in the skin via
sun exposure. Vitamin D is hydroxylated to form calcitriol, which has a major role regulating the
concentration of calcium and phosphate for bone growth and remodeling. Recently, calcitriol has also
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been identified to have important functions in regulating immune and inflammatory responses [60].
Lower levels of vitamin D were seen in the periodontitis population and in both sexes, with a greater
difference in females with periodontitis compared to normal (non-periodontitis) females, as shown in
Figure 4A. Lower levels were consistently noted across the entire age range of patients with rather
minimal variation with aging, as shown in Figure 4B. The lowest levels of vitamin D were noted
in patients with moderate periodontitis, particularly in patients over 50 years of age, as shown in
Figure 4C,D. Figure 4E shows exceptionally low vitamin D levels in all black subjects with decreased
levels in both black and Hispanics with moderate periodontitis. There was a decreased level of vitamin
D in females with all levels of periodontitis and a nearly 2-fold decrease in females with moderate
periodontitis, as shown in Figure 4F, with no differences seen in males. Smokers did not appear to
have decreased vitamin D levels, although disease in both smokers and non-smokers was generally
associated with lower vitamin D levels, as shown in Figure 4G.
Figure 4. Levels of vitamin D (ng/mL) in subjects with or without periodontitis stratified upon sex
(A), age (B), disease severity (C), disease severity and age (D), race/ethnicity (E), disease severity and
sex (F), and disease severity in smokers (G). The bars denote group means and the vertical brackets
enclose 1 SEM. The asterisk (*) denotes significantly different than the normal group at p < 0.05.
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Vitamin E is a group of eight fat-soluble compounds including tocopherols and tocotrienols that
can act as antioxidants and easily penetrate cell membranes. Levels of vitamin E were increased in both
normal males and females compared to periodontitis, as shown in Figure 5A. This was particularly
noted with lower levels observed in periodontitis patients >30 years of age, and the largest difference
from normal subjects was seen in the oldest disease patients, as shown in Figure 5B. While all levels
of periodontitis showed lower vitamin E levels, only the moderate disease group reached statistical
significance, as shown in Figure 5C. As seen in the overall population, patients >30 years of age
showed lower levels of vitamin E related to periodontitis severity and age compared to normal
subjects, as shown in Figure 5D. Generally, disease patterns in vitamin E levels were not noted based
on race/ethnicity, albeit the black subjects routinely had the lowest levels of vitamin E, as shown in
Figure 5E. Based upon the severity of the disease, males showed no differences in vitamin E levels and
while females with moderate disease had decreased blood levels of vitamin E, there was no particular
pattern of alterations related to disease versus normal subjects, as shown in Figure 5F. Similarly, rather
minimal differences were observed when subjects were classified based upon smoking, as shown in
Figure 5G.
Figure 5. Levels of vitamin E (µg/dL) in subjects with or without periodontitis stratified upon sex (A),
age (B), disease severity (C), disease severity and age (D), race/ethnicity (E), disease severity and sex
(F), and disease severity in smokers (G). The bars denote group means and the vertical brackets enclose
1 SEM. The asterisk (*) denotes significantly different than the normal group at p < 0.05.
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The previous results presented the five nutrients individually related to disease and various
demographic characteristics. However, the functional activity of these nutrients would be expected to
be acting in concert, with potential additive or synergistic contributions to the overall susceptibility or
resistance to periodontal disease initiation and progression. Thus, we employed the FSA to estimate
the varying effects of blood nutrient levels within age, race/ethnicity, and sex that are significantly
associated with periodontal health. Two significant and near significant interactions were found from
the FSA analysis. Vitamin D and folate were found to have varied effects for different subgroups
of sex, age, and race, respectively. All reported interaction odds ratios were adjusted for the main
effect of age, ratio of family income to poverty, sex, and race and interpreted using a log standardized
scale. One additional log standardized unit of vitamin D in females had an estimated adjusted odds of
periodontal disease 0.86 (95% CI: 0.71, 1.03; p-value = 0.124) times that of males. One additional log
standardized unit of folate in whites had an estimated adjusted odds of periodontal disease 0.78 (95%
CI: 0.61, 1.01; p-value = 0.059) times that of Hispanics.
4. Discussion
Periodontitis is considered a dysregulation of host responses to an evolving dysbiotic microbiome
at sites of lesions reflecting a chronic local inflammatory environment [36,61]. While data derived
from technologies developed for the Human Microbiome Project [62] to profile the members and
functions of the bacteria in health and pathogenic biofilms [63] has provided new insights into this
microbial dysbiosis, there appears a clear role for individual genetic variation across the population
that contributes to disease expression and severity [17,19,24,26,30,64–66]. Furthermore, aging and
race/ethnicity increase the risk for the extent/severity of periodontitis [67], and more recently,
gene-environment interactions contributing to disease have emphasized the importance of the
exposome in affecting disease risk [27,29,68].
In a previous study of the exposome using NHANES data from 1999–2004, we identified
more classical factors (i.e., age, gender, race/ethnicity) in disease prevalence, and for the first time
incorporated a broad array of environmental variables that significantly enhanced the prevalence of
periodontitis in the population [47]. However, we also noted a select group of blood nutrients that
demonstrated a significant protective odds ratio for periodontitis that showed an increased affect
with aging.
This exploratory report provides additional details on five of the blood nutrients—cis-β-carotene,
folate, vitamin D, vitamin E, and β-cryptoxanthin—that demonstrated these protective associations.
There are over 600 known carotenoids: [xanthophylls (β-cryptoxanthin, lutein, zeaxanthin; non-vitamin
A carotenoids) and carotenes (β-carotene, α-carotene, lycopene)]. Generally, the health benefits of
carotenoids are considered to interact with endogenous antioxidant enzymes to positively affect
inflammation and immune responses [69]. Carotenoids have been shown to alter intracellular
inflammatory signaling pathways (e.g., NFκB) and inflammatory mediator profiles [70]. These effects
have been evaluated in various studies related to periodontal disease. Periodontitis leads to significant
increases in an array of systemic acute phase proteins, with the literature supporting increased systemic
inflammation with low vitamin A levels [71,72]. Our data demonstrated a significantly decreased
level in cis-β-carotene in the serum of periodontitis patients with a greater divergence—in the subjects
with a normal periodontium and advancing age. This is consistent with a report of an inverse
relationship between elevated carotenoids and serum C-reactive protein (CRP) levels in 60–70 year
old men [73], as well as data supporting a link between dietary carotenoids and cognitive functions
in humans [74]. We noted this difference from blood levels in subjects with a normal periodontium
that was accentuated with more severe disease in the aging population. Our data also showed this
relationship with more severe disease across racial/ethnic groups, particularly in white and black
subjects, and in both smokers and non-smokers. These effects have been evaluated in a limited number
of studies related to periodontal disease. Low blood levels of various carotenoids were correlated
with an increased prevalence of periodontitis in older men [50]. Moreover, in non-smokers, serum
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carotenoid levels interacted with clinical improvement in periodontitis following scaling and root
planing [39]. Our findings from the large NHANES cohort supports these findings and suggested that
increased dietary availability of carotenoids could contribute to a treatment strategy for increasing
prevalence of periodontitis with aging.
Dietary β-cryptoxanthin, another carotenoid, also displays anti-inflammatory activities
that positively affect various chronic inflammatory diseases including polyarthritis [75] and
osteoarthritis [76]. Data from studies of inflammation in metabolic syndrome supported an effect
on regulating NF-κB and Nrf2 pathways that control inflammatory mediators and antioxidant
proteins [77]. Findings from Matsumoto et al. [78] found that β-cryptoxanthin suppressed
lipopolysaccharide (LPS)-induced osteoclast formation and lowered alveolar bone loss in a mouse
model and decreased Porphyromonas gingivalis-induced IL-6 and IL-8 production by human periodontal
ligament cells [79]. As noted by Toti et al. [80], this type of dietary immunomodulatory could be
considered part of a personalized nutritional or supplementation strategy for preventing and treating
chronic inflammatory conditions, such as periodontitis.
Folate is one of the B vitamins found mainly in dark green leafy vegetables, beans, peas and
nuts, and fruits (oranges, lemons, bananas, melons, and strawberries). Humans cannot produce folic
acid making it an essential nutrient required from the diet and critical for synthesis of DNA, RNA,
and metabolizing amino acids. While folate has been most directly linked to pregnancy and preventing
neural tube defects and a type of anemia, supplementation has been associated with some reductions
in the risk of cardiovascular disease [81]. Folic acid has also been shown to regulate inflammation
driven by release of endogenous danger-associated molecular pattern (DAMP) molecules [82], as well
as regulating reactive oxygen species production during hypoxia [83]. However, a recent clinical trial
did not identify an impact on systemic inflammation and endothelial dysfunction in women [84].
Previous findings have reported lower folic acid levels in smokers with periodontal disease [85] and
that elevated folate (B-complex) levels provided a positive impact on nonsurgical periodontal therapy
and periodontal wound healing [86]. However, these same authors suggested a general lack of data to
support an impact of nutritional supplementation, including B-complex, on preventing periodontal
disease [87]. Staudte et al. [88] did demonstrate that a lower intake of dietary folic acid was related to an
increased prevalence of periodontitis. Our results demonstrated lower folate levels with periodontitis,
particularly in subjects >30 years old, which was reflected in patterns for all levels of disease extent.
Additionally, lower folate levels paralleled disease extent in white subjects and in smokers, with an
opposite presentation in Hispanic subjects that is not readily explained from the existing literature
of folate levels in this ethnic group. Interestingly, our findings with folate, using somewhat different
clinical definitions on a broader NHANES population base, reflected the results of Yu et al. [89] who
reported that low folate levels were an independent risk factor for periodontal disease in older adults.
Thus, while this exploratory study only provides associational outcomes, this dietary nutrient may
contribute as a clinical target for prevention or early intervention in effectively managing periodontal
health, particularly in the aging population.
Numerous reports have linked increased levels of vitamin D with minimizing tooth loss resulting
from periodontitis [90–96]. Additionally, vitamin D receptor polymorphisms [97] and for vitamin D
binding protein appear to have some impact on increasing the risk for periodontitis [98,99]. Research
has also found that patients with low serum vitamin D levels, exhibited healing from periodontal
surgery was adversely affected [100]. Related to these clinical findings, vitamin D improves epithelial
innate immune functions and antimicrobial peptide secretion [101–103] and down-regulates NFκB
activation and cytokine secretion by monocytes and macrophages [104,105]. Additionally, from the
microbiome side of the periodontal disease equation, vitamin D decreases virulence gene expression
by P. gingivalis [104,105]. Our analysis of this nutrient based upon examination of NHANES data
demonstrated lower blood levels in periodontitis patients across the entire age range, suggesting
the potential for a protective relationship. This difference was exacerbated in older individuals with
moderate periodontitis, and particularly in black and Hispanic subjects. This was an unexpected
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finding as one might hypothesize a dose effect, whereby this type of protective nutrient would be
more greatly affected in severe periodontitis patients. Potentially, those patients with moderate disease
are most affected by alterations in this nutrient, while the mild disease individuals with lower levels
exhibited a relationship with periodontitis that was more variable in the heterogeneous population.
Moreover, with the severe disease patients, existing literature supports that this might be a unique
subset of patients with multiple risk factors (e.g., genetics, microbiome) increasing the risk of severity
of disease [67–106] that may simply overwhelm any impact of the vitamin D effects. The effect of
vitamin D was also observed in both smokers and non-smokers. This relationship of vitamin D levels
and general health has also been reported using NHANES data [107–109], suggesting an important
role for enhancing the proportion of the population of all age groups with normal levels of vitamin D.
The tocopherols and tocotrienols occur in α, β, γ, and δ forms with γ-tocopherol the most
common form of vitamin E found in the North American diet and is the major tocopherol in corn
oil and soybean oil, while α-tocopherol is the most biologically active form of vitamin E. These are
fat-soluble antioxidants that help block the formation of reactive oxygen species by interacting with
cellular membranes and adipose tissues. An increased consumption of vitamin E has been related to a
lower incidence of cardiovascular disease (CVD), cancer and dementia, although data from randomized
trials did not consistently demonstrate an effect with these diseases [110–113]. The literature with
vitamin E in periodontitis is somewhat limited. Patients with serum α-tocopherol levels that were in
the low normal range displayed an increased severity of periodontitis [114]. Dietary or supplements
with vitamin E showed a positive impact on clinical measures of chronic periodontitis, potentially
through their effect on oxidative stress reactions to chronic inflammation [115]. A study of scaling and
root planing with vitamin E supplementation appeared to improve periodontal wound healing and
improved serum and salivary superoxide dismutase activities [116]. Moreover, increased dietary intake
of α-tocopherol with other antioxidants and anti-inflammatory omega-3 fatty acids reduced probing
depths in chronic periodontitis that was limited to only non-smokers [39]. In contrast, while Linden
et al. [50] found an effect of carotenoids on periodontitis in older men, serum vitamin E levels were
unrelated to disease. Mechanistically, α-tocopherol has been shown to modulate the production of
reactive oxygen species by neutrophils following activation by FcγR and TLR ligands [117]. This form
of vitamin E also decreases gingival fibroblast production of IL-1β and IL-6, while increasing various
human β-defensins following challenge with LPS from P. gingivalis [118]. Thus, numerous studies
support the potential that optimal vitamin E levels may contribute to an overall improved host
anti-inflammatory environment, particularly in concert with a panel of dietary nutrients directed
toward controlling oxidative stress and associated chronic inflammatory reactions.
This report describes an associational study of a large US population sampled over an interval
of 5 years via the NHANES project and demonstrated statistical associations of a subset of serum
nutrients to the expression of periodontitis. The concept of diet impacting periodontal disease has been
the subject of a number of reports [45,46] that can be implemented via specific strategies related to
food intake [39,88] and specific supplementation [119]. While these studies have often focused on the
capacity of these nutrients to act as antioxidants cooperating with endogenous host antioxidant
biomolecules [40], an important concept that emerges is a lower likelihood of a single nutrient
provided through food or supplements as being optimally effective in the prevention or treatment
of inflammation and alveolar bone loss in periodontitis. However, targeted combinations of these
biologically active nutrients may provide a solid strategic adjunctive approach to the management of
periodontitis, particularly with aging. Our results indicated interactions between vitamin D and sex,
and race and folate. The estimated effect of vitamin D was shown to be more protective in females
than males. Moreover, the estimated protective effect of folate was greater in whites than it was
in Hispanics.
As with all cross-sectional observational epidemiologic studies, this evaluation cannot define a
cause and effect relationship between the functions of the nutrients and disease outcomes. Moreover,
it is well recognized that the NHANES clinical design did not provide the detailed clinical evaluation
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of periodontitis that represents current concepts of disease expression and progression. However,
the findings related to the potential impact on disease in aging, associated with race/ethnicity as a
risk for disease, and smoking effects, suggest that the nutrient components could be evaluated in
more prospective studies, to delineate causal linkages in protection from expression of periodontitis.
Delivery of an optimized combination of these nutrients at each meal or via snacks, in combination
with adequate measures of standard oral hygiene care, may provide evidence for an important role in
the prevention of periodontitis.
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